DACS
COGT icon

Dymon Asia Capital (Singapore)’s Cogent Biosciences COGT Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Hold
22,700
– – 0.04% 170
2026
Q1 		$874K Sell
22,700
-1,500
-6% -$55.4K 0.09% 184
2025
Q4 		$860K Buy
+24,200
New +$680K 0.08% 175

Other funds holding COGT

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s COGT Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) held its Cogent Biosciences (COGT) position steady in Q2 2026 at 22,700 shares worth $878K. The position accounts for 0.04% of the portfolio, ranked #170.

Dymon Asia Capital (Singapore) first reported a position in COGT in Q4 2025 and has held it in 3 quarters since. 47 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 22,700 shares of Cogent Biosciences worth $878K as of Q2 2026.
  • Dymon Asia Capital (Singapore) left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up 0.04% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #170 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Cogent Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 47 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.